Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. 4 Grant or award Chief Executive Officer acquired 3,378 shares (grant or award)
  2. S-3 Offering Registration Statement
  3. D Other Notice of Sales of Unregistered Securities
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. SCHEDULE 13D/A Stake Beneficial Ownership Report
  6. 4 Grant or award Chief Executive Officer acquired 153,550 shares (grant or award)
  7. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  8. 8-K Event Other events
  9. 4 Grant or award Chief Executive Officer acquired 1,671 shares (grant or award)
  10. 4 Grant or award Director acquired 19,000 shares (grant or award)
  11. 4 Grant or award Director acquired 19,000 shares (grant or award)
  12. 4 Grant or award Director acquired 19,000 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 64,609 shares (grant or award)
  14. 4 Grant or award President acquired 64,609 shares (grant or award)
  15. 4 Grant or award Director acquired 19,000 shares (grant or award)
  16. 4 Grant or award Director acquired 19,000 shares (grant or award)
  17. 4 Grant or award Chief Executive Officer acquired 96,913 shares (grant or award)
  18. 4 Grant or award Director acquired 19,000 shares (grant or award)
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 8-K Event Executive or director change · Shareholder vote results

Page 2 of 38 · 753 filings